Teicoplanin is indicated for serious Gram-positive infections including MRSA, endocarditis, and bone/joint infections. It offers strong efficacy with lower nephrotoxicity than vancomycin, making it safer for prolonged use. Convenient dosing and stable levels ensure reliable treatment in ICU and ward settings.